A Wild Stem Cell Chase

A rigorous new study provides strong evidence that very small embryonic-like stem cells hypothesized to be found in mice and humans do not exist.

Written bySigne Cane
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, NISSIM BENVENISTYThe existence of very small embryonic-like stem cells (VSELs) has been hotly debated by scientists since they were first reported in mouse bone marrow in 2005. The cells were later identified in human blood and bone marrow as well, and have been proposed as a viable alternative to mouse and human embryonic stem cells (ESCs) in research and medicine. But a study published today (July 24) in Stem Cell Reports has called the very existence of VSELs in question, with the senior author deeming them a “distraction.”

“The results cast strong doubt on the existence of pluripotent VSELs in the bone marrow,” said Martin Pera, chair of Stem Cell Sciences at the University of Melbourne in Australia, who was not involved in the study. “Many previous reports claiming to identify pluripotent stem cells in adult tissues have similarly failed to stand up to careful scrutiny.”

Mariusz Ratajczak, director of the Developmental Biology Research Program at the University of Louisville, is widely credited as the discoverer of VSELs. He has claimed to isolate VSELs from mouse and human tissues, estimating them to be 3–5 micrometers in size and noting that they express pluripotent marker genes. Ratajczak has suggested that VSELs may possess embryonic-stem-cell-like qualities and has argued that finding such cells in an ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies